Impact of MELD-based allocation on end-stage renal disease after liver transplantation

American Journal of Transplantation

Volumn 11, Issue 11, 2011, Pages 2372-2378

  Sharma, P ^a   Schaubel, D E ^b   Guidinger, M K ^c   Goodrich, N P ^c   Ojo, A O ^a   Merion, R M ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

End stage renal disease; Liver transplant; Model for end stage renal disease; Mortality; Scientific registry of transplant recipients

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; SODIUM;

ADULT; ARTICLE; DIABETES MELLITUS; ETHNICITY; FEMALE; HEPATITIS C; HUMAN; INCIDENCE; KIDNEY FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL;

ADULT; AGED; END STAGE LIVER DISEASE; FEMALE; HEALTH CARE RATIONING; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; UNITED STATES;

EID: 84857194103     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03703.x     Document Type: Article

References (16)

1. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940. (Pubitemid 37064766)
2. Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS. Reweighting the model for end-stage liver disease score components. Gastroenterology 2008; 135: 1575-1581.
3. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us? Am J Transplant 2006; 6: 2651-2659. (Pubitemid 44571685)
4. Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS. Renal outcomes after liver transplantation in the model for endstage liver disease era. Liver Transpl 2009; 15: 1142-1148.
5. Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE. Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 2006; 6: 1228-1242.
6. Dickinson DM, Bryant PC, Williams MC, et al. Transplant data: Sources, collection and caveats. Am J Transplant 2004;(Suppl 9): 13-26. (Pubitemid 38858992)
7. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data, 2nd Ed. New York: Wiley, 2002.
8. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 2007; 26: 2389-2430. (Pubitemid 46730255)
9. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994; 331: 1110-1115.
10. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361-365.
11. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179-1185. (Pubitemid 34454015)
12. Campbell MS, Kotlyar DS, Brensinger CM, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005; 11: 1048-1055. (Pubitemid 41341753)
13. Bahirwani R, Campbell MS, Siropaides T, et al. Transplantation: Impact of pretransplant renal insufficiency. Liver Transpl 2008; 14: 665-671. (Pubitemid 351696279)
14. Berg CL, Steffick DE, Edwards EB, et al. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009; 9: 907-931.
15. Rakela J, Vargas HE. Hepatitis C: Magnitude of the problem. Liver Transpl 2002; 8: S3-S6.
16. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790. (Pubitemid 43345017)